NCT05163821

Brief Summary

Aims

  • The investigators want to find out if the tool that they have made to assess memory and thinking in Somali elders ( the 'MSCAT') is acceptable to that community and practical to administer and score.
  • The public will benefit from this research because it seeks to enhance reliability of diagnosis of dementia, thus access to support and treatment for people from an ethnic minority group experiencing memory problems. Background
  • The investigators are a group of staff from the Memory Assessment Service in Manchester. There are currently no suitable tests for dementia for people from Somalia.
  • Research evidence tells us there are many reasons why the tools that used now are not working. This includes: differences in culture and ways of life that are very different to a British born person who has lived in the UK for all of their life.
  • Somali people find out at a later stage if they have dementia resulting in delayed treatment/support.
  • This research supports the government's promise to improve the pathway to a diagnosis of dementia for minority groups. Design and methods
  • 10 participants
  • The investigators will compare the assessment tool (MSCAT) that the team have developed to the Addenbrookes Cognitive Examination III tool that is typically used.
  • Participants will be seen at an agreed location (e.g. home, mosque or GMMH trust site). They will meet a Somali speaking researcher to do both tests on 2 appointments and discuss how they found the tests afterwards.
  • The investigators will check participants understanding of the research before they agree to take part. Verbal and written information will be provided. Public involvement
  • The local Somali community helped advise on the creation of the new MSCAT assessment tool.
  • The investigators will write project information for participants in Somali and English. Dissemination of results
  • Professional conference presentations and publications

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jan 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 7, 2021

Completed
13 days until next milestone

First Posted

Study publicly available on registry

December 20, 2021

Completed
19 days until next milestone

Study Start

First participant enrolled

January 8, 2022

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 4, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 4, 2023

Completed
Last Updated

December 18, 2023

Status Verified

December 1, 2023

Enrollment Period

1.9 years

First QC Date

December 7, 2021

Last Update Submit

December 15, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Qualitative feedback on completing the cognitive screens

    Interview

    Immediately after completing the screen

Study Arms (1)

Participants

Somali migrants in UK, aged over 50.

Diagnostic Test: Manchester Somali Cognitive Assessment ToolDiagnostic Test: ACE-III Somali Translation

Interventions

Cognitive screen for dementia

Participants

Cognitive screen for dementia

Participants

Eligibility Criteria

Age50 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Somali-born migrants in UK

You may qualify if:

  • The participants will all be Somali-born migrants, over the age of 50, living in the UK.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Greater Manchester Mental Health NHS Trust

Manchester, M13 9WL, United Kingdom

Location

MeSH Terms

Conditions

Dementia

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesNeurocognitive DisordersMental Disorders

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Clinical Psychologist

Study Record Dates

First Submitted

December 7, 2021

First Posted

December 20, 2021

Study Start

January 8, 2022

Primary Completion

December 4, 2023

Study Completion

December 4, 2023

Last Updated

December 18, 2023

Record last verified: 2023-12

Locations